Categories: News

Dynatronics Corporation Announces Participation in Investor Conferences

Investor Summit: May 17-18, 2021

Canaccord Genuity 2021 Musculoskeletal Conference: May 20, 2021

EAGAN, MN / ACCESSWIRE / May 6, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that management will participate in two investor conferences in May 2021, to provide an update on the company’s business and recently announced product portfolio optimization plan.

John Krier, President and CEO of Dynatronics Corporation, and other members of the company’s leadership team will participate in the Investor Summit being held virtually on May 17-18, 2021 and will also participate in the Canaccord Genuity 2021 Virtual Musculoskeletal Conference on May 20, 2021. Management will be available for one-on-one meetings and will present in a group format at each of these conferences. Investors interested in scheduling one-on-one meetings are encouraged to register online, or may contact Skyler Black of Dynatronics Corporation or Peter Seltzberg of Darrow Associates.

The group presentation for the Investor Summit is scheduled for 2:45 PM ET on May 18, 2021 and the group presentation for the Canaccord Genuity 2021 Virtual Musculoskeletal Conference is scheduled for 3:30 PM ET on May 20, 2021. A live webcast of the group presentation at Investor Summit can be accessed on the company’s Investor webpage under the Events & Presentations tab at https://irdirect.net/DYNT/events_and_presentations/1982. This webcast will be archived on the website for future viewing.

About Dynatronics Corporation

Dynatronics Corporation is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company’s products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Dynatron Solaris®, Hausmann™, Physician’s Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.

Investor Contacts:

Dynatronics Corporation
Investor Relations
Skyler Black
(801) 676-7201
ir@dynatronics.com

Darrow Associates
Peter Seltzberg, Managing Director
(516) 419-9915
pseltzberg@darrowir.com

For additional information, please visit: www.dynatronics.com.

Connect with Dynatronics on LinkedIn.

SOURCE: Dynatronics Corporation

View source version on accesswire.com:
https://www.accesswire.com/644921/Dynatronics-Corporation-Announces-Participation-in-Investor-Conferences

Staff

Recent Posts

Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

34 minutes ago

Functional Brands Inc. Launches Kirkman’s(R) Skin, Beauty & Anti-Aging Bundle: A Science-Backed Approach to Radiant, Resilient Skin

Comprehensive Formula Featuring Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed ExtractLake Oswego, Oregon--(Newsfile Corp.…

34 minutes ago

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

2 hours ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

3 hours ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

3 hours ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

3 hours ago